Literature DB >> 3713112

Left heart function in chronic obstructive lung disease.

H Seibold, U Roth, R Lippert, J Kohler, S Wieshammer, E Henze, M Stauch.   

Abstract

In patients with varying degrees of chronic obstructive pulmonary disease (COPD), simultaneous measurements of central hemodynamics and left ventricular radionuclide ventriculograms at rest and during exercise were made. In 21 of these patients, satisfactory echocardiograms could be performed. In seven of the patients, arterial blood pressure at rest was increased. Decreased compliance of the left ventricle was thought to be present in patients with COPD and additional arterial hypertension. The left ventricular ejection fraction (LVEF) at rest was in the high normal range in all patients. During exercise, no further increase was observed. This pattern of LVEF response seems to be typical in patients with COPD. Because the highest values were observed in the more severe COPD and right ventricular hypertrophy, it is unlikely that an impairment of left ventricular function is caused by COPD. In five of 27 patients, an abnormal decrease of LVEF and regional hypokinesis occurred during exercise, thus suggesting additional coronary heart disease. The fact that at least 30% of the patients with COPD suffered from arterial hypertension and 20% of the patients exhibited unexpected ischemia detected by regional hypokinesis in RNV during exercise, but not in the ECG, may be of practical relevance. Coronary angiography was not indicated because most of these patients were over 65 and the factor limiting the working capacity was ventilatory impairment and not angina pectoris, in all patients. For this reason, a diagnostic uncertainty remains with regard to additional coronary heart disease in the older patients with advanced chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  1986        PMID: 3713112     DOI: 10.1007/bf01727529

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  51 in total

1.  Factors which affect the diastolic pressure-volume curve.

Authors:  S A Glantz; W W Parmley
Journal:  Circ Res       Date:  1978-02       Impact factor: 17.367

2.  Compliance of the left ventricle.

Authors:  H J Levine
Journal:  Circulation       Date:  1972-09       Impact factor: 29.690

3.  Lung function in chronic obstructive lung disease and coexistent left heart failure.

Authors:  H Bass
Journal:  Am J Med       Date:  1970-04       Impact factor: 4.965

4.  Congestive heart failure masquerading as primary pulmonary disease.

Authors:  E C Rosenow; C E Harrison
Journal:  Chest       Date:  1970-07       Impact factor: 9.410

5.  Left ventricular function before and after reaching the anaerobic threshold.

Authors:  C A Boucher; M D Anderson; M S Schneider; J H Murphy; R D Okada; D J Kanarek
Journal:  Chest       Date:  1985-02       Impact factor: 9.410

Review 6.  Diastolic properties of the left ventricle.

Authors:  W Grossman; L P McLaurin
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

7.  Limitations of radionuclide ventriculography in the non-invasive diagnosis of coronary artery disease. A correlation with right heart haemodynamic values during exercise.

Authors:  S Wieshammer; C Delagardelle; H A Sigel; E Henze; P Kress; F Bitter; R Lippert; H Seibold; W E Adam; M Stauch
Journal:  Br Heart J       Date:  1985-06

8.  Effect of age on the response of the left ventricular ejection fraction to exercise.

Authors:  S Port; F R Cobb; R E Coleman; R H Jones
Journal:  N Engl J Med       Date:  1980-11-13       Impact factor: 91.245

9.  Evaluation of left ventricular function in chronic pulmonary disease by exercise gated equilibrium radionuclide angiography.

Authors:  R Slutsky; W Hooper; W Ackerman; W Ashburn; K Gerber; K Moser; J Karliner
Journal:  Am Heart J       Date:  1981-04       Impact factor: 4.749

10.  Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations.

Authors:  W Grossman; E Braunwald; T Mann; L P McLaurin; L H Green
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

View more
  1 in total

1.  Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial.

Authors:  Miguel J Divo; Michael R DePietro; John R Horton; Cherie A Maguire; Bartolome R Celli
Journal:  Respir Res       Date:  2020-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.